【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, September 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, September 2013 14
2.2.1 Tenet Healthcare Prices Private Placement of Notes for US$4.6 Billion 14
2.2.2 Fresenius to Acquire 43 Hospitals from Rhon-Klinikum for US$4.1 Billion 14
2.2.3 Suntory Beverage to Acquire Lucozade and Ribena Brands from GlaxoSmithKline for US$2.1 Billion 15
2.2.4 Aspen Pharmacare to Acquire Thrombosis Brands and Manufacturing Facility from GlaxoSmithKline for US$1.13 Billion 16
2.2.5 AbbVie Enters Into Licensing Agreement with Ablynx for ALX-0061 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, September 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, September 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, September 2013 20
3.1.1 Top M&A Deals in September 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, April 2013 – September 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, September 2013 24
3.2.1 Top Equity Offering Deals in September 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, April 2013 – September 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, September 2013 29
3.3.1 Top PE/VC Deals in September 2013 31
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, September 2013 32
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, September 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, April 2013-September 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, April 2013-September 2013 38
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2013 39
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2013 39
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, April 2013 – September 2013 41
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), September 2013 43
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, September 2013 44
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), April 2013 – September 2013 45
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, April 2013 – September 2013 47
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), April 2013 – September 2013 48
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), April 2013 – September 2013 50
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2013 52
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2013 52
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2013 54
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, September 2013 56
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, September 2013 56
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, September 2013 57
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), April 2013 – September 2013 58
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), April 2013 – September 2013 60
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), April 2013 – September 2013 62
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), April 2013 – September 2013 64
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 66
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, September 2013 66
6.1.1 Oncology – Deals of the Month 68
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, September 2013 70
6.2.1 Central Nervous System – Deals of the Month 71
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, September 2013 72
6.3.1 Infectious Diseases – Deals of the Month 74
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, September 2013 75
6.4.1 Immunology – Dealsof the Month 77
6.5 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, September 2013 78
6.5.1 Respiratory – Deal of the Month 80
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, September 2013 81
6.6.1 Cardiovascular – Deal of the Month 83
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, September 2013 84
6.7.1 Metabolic Disorders – Deal of the Month 86
7 Deal Summary by Geography 87
7.1 Pharmaceuticals & Healthcare, North America Deals, September 2013 87
7.1.1 North America – Deals of the Month 89
7.2 Pharmaceuticals & Healthcare, Europe, Deals, September 2013 92
7.2.1 Europe – Deals of the Month 94
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, September 2013 96
7.3.1 Asia-Pacific – Deals of the Month 98
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, September 2013 99
7.4.1 Rest of the World – Deals of the Month 100
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 101
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, April 2013 – September 2013 101
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, April 2013 – September 2013 103
9 Further Information 105
9.1 Methodology 105
9.2 About GlobalData 106
9.3 Disclosure information 107
9.4 Disclaimer 107
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：September 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for September 2013 in Pharmaceuticals
■ 発行日：2013年10月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162558
■ 調査対象地域：グローバル
- 液化石油ガス産業分析：Liquefied Petroleum Gas ? An Industrial AnalysisLiquefied petroleum gas (LPG) is a non-renewable source of energy. It is extracted from crude oil and natural gas. The main composition of LPG are hydrocarbons containing three or four carbon atoms. The normal components of LPG thus, are propane and butane. Small concentrations of other hydrocarbons may also be present. Depending on the source of the LPG and how it has been produced, components ot …
- インドの麻酔装置・呼吸装置市場India Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "India Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management …
- 韓国の麻酔装置・呼吸装置市場South Korea Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "South Korea Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain …
- MK-3102 (Type 2 Diabetes)：市場予測と分析（～2022）MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more …
- ヘルスケア向けモバイルソリューションの世界市場2015-2022According to Stratistics MRC, the Global Healthcare Mobility Solutions market is accounted for $24.3 billion in 2015 and is expected to reach $144.8 billion by 2022 growing at a CAGR of 29.04% from 2015 to 2022. Improving various technological advancements in wireless network connectivity, growing adoption of electronic gadgets are the major drivers favoring the market growth. The factors such as …
- 世界における医用画像情報システムの製品パイプライン動向2015Medical Imaging Information Systems - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Medical Imaging Information Systems - Pipeline Review, 2015" provides an overview of Medical Imaging Information Systems currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of dev …
- マレーシアの健康サプリメント市場2015-2019Technavio’s research analyst predicts the health supplement market in Malaysia to grow at a CAGR of 7% during the forecast period. The rise in the aging population in Malaysia is the key driver for the market growth of this region. Products that prevent age-related disorders, such as those linked to the digestive system, and ones that help maintain blood sugar levels, are in high demand among this …
- 世界のIAM（アイデンティティー&アクセス管理）市場Organizations are transitioning from traditional Identity (ID) management to cloud ID management, as the need for affordable and manageable identity management solutions and popularity of cloud models are increasing. Traditionally, most of the companies have on-premise Identity and Access Management (IAM) solutions, but with an increasing trust in cloud-based services, the market for IAM across sm …
- カオリンの世界市場動向2014/2015The report presents a thorough study of kaolin, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing kaolin worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: kaolin production in the country, major manufacturers …
- 建物・建設産業向けナノコーティング剤の世界市場2017-2021About nanocoatings Nanocoatings coat surfaces with nanostructures that form a uniform network of molecules. The thickness of these coatings is measured in nanoscales. Technavio’s analysts forecast the global nanocoatings market for the building and construction industry to grow at a CAGR of 20.41% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the …
- US Flow Cytometry Market 2014: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive LandscapeComplete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300.This report presents a comprehensive analysis of the US flow cytometry market, including:Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume …
- スマートアドバイザーの世界市場予測（～2021年）The smart advisors market size is estimated to grow from USD 703.3 Million in 2016 and to USD 3,172.0 Million by 2021, at a CAGR of 35.2% from 2016 to 2021. Some of the major factors that are driving the growth of the market include the proliferating demand of intelligent customer engagement, increasing penetration of websites & mobile applications, and surge in demand of automated patient managem …
- 民間航空機ウインドー及びフロントガラスの世界市場2016-2020About Windows in Aircraft Passenger Cabins Windows in aircraft passenger cabins are smaller in size to maximize the areas of the hull between them and to increase the mechanical strength of the airframe. From a technical point of view, an aircraft fuselage would be much stronger if it could completely remove cut-outs for windows and windshields. In the 1970s, there were incidents in several De Hav …
- 酸化プロピレン(PO)の世界市場予測Propylene oxide 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about propylene oxide market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytica …
- パセリの世界市場2018-2022About this market Increasing demand for fresh herbs to drive market growth. Organic and fresh farming practices are gaining popularity across the world. As such, many parsley producers are shifting to organic farming practices. Technavio’ s analysts have predicted that the parsley market will register a CAGR of over 4% by 2023. Market Overview Growing focus on presentation and attractive plating W …
